US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Magnesium Sulfate 200 mg/mL

Reason Lack of sterility assurance.

Guardian Pharmacy Services D-1060-2018
Class I · High risk Terminated

7K capsules packaged in single packs sold in 24-count boxes

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Shoreside Enterprises Inc. D-0880-2018
Class I · High risk Terminated

POSEIDON Xtreme PLATINUM 4500

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Shoreside Enterprises Inc. D-0879-2018
Class II · Moderate risk Terminated

My Way

Reason Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.

Lupin Pharmaceuticals Inc. D-0838-2018
Class II · Moderate risk Terminated

My Way

Reason Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.

Lupin Pharmaceuticals Inc. D-0837-2018